Rational Targeting of Cellular Cholesterol in Diffuse Large B-Cell Lymphoma (DLBCL) Enabled by Functional Lipoprotein Nanoparticles: A Therapeutic Strategy Dependent on Cell of Origin

Document Details

Document Type
Pub Defense Publication
Publication Date
Oct 03, 2017
Source ID
10.1021/acs.molpharmaceut.7b00710

Entities

People

  • Amir Behdad
  • Colby Thaxton
  • Jonathan S. Rink
  • Kaylin M. Mcmahon
  • Leo I. Gordon
  • Osman Cen
  • Richard Longnecker
  • Shuo Yang
  • Sol Misener
  • Tim Taxter

Organizations

  • Howard Hughes Medical Institute
  • National Cancer Institute
  • National Heart, Lung, and Blood Institute
  • Northwestern University
  • Tim Lindenfelser Lymphoma Research Fund
  • United States Department of Defense

Tags

Technology Areas

  • Biotechnology
  • Biotechnology - Cancer Biotech